# Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.

> **NCT01275443** · PHASE1 · COMPLETED · sponsor: **St Stephens Aids Trust** · enrollment: 66 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** 300mg TMC278LA
- **DRUG:** 150mg TMC278LA
- **DRUG:** 1200mg TMC278LA
- **DRUG:** 600mg TMC278LA

## Key facts

- **NCT ID:** NCT01275443
- **Lead sponsor:** St Stephens Aids Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01275443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01275443, "Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01275443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*